1. Home
  2. LGO vs PYPD Comparison

LGO vs PYPD Comparison

Compare LGO & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LGO

Largo Inc.

HOLD

Current Price

$0.97

Market Cap

104.6M

Sector

N/A

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.74

Market Cap

85.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGO
PYPD
Founded
1988
2008
Country
Canada
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
104.6M
85.1M
IPO Year
2007
2014

Fundamental Metrics

Financial Performance
Metric
LGO
PYPD
Price
$0.97
$4.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$3.25
$12.25
AVG Volume (30 Days)
896.4K
102.7K
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$50.56
N/A
Revenue Next Year
$59.94
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.85
$2.72
52 Week High
$2.70
$5.20

Technical Indicators

Market Signals
Indicator
LGO
PYPD
Relative Strength Index (RSI) 31.98 54.33
Support Level $0.88 $4.15
Resistance Level $1.26 $5.05
Average True Range (ATR) 0.07 0.27
MACD -0.01 0.03
Stochastic Oscillator 8.85 53.92

Price Performance

Historical Comparison
LGO
PYPD

About LGO Largo Inc.

Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: